Legal Advantage Investments Inc. Makes New $493,000 Investment in Astera Labs, Inc. $ALAB

Legal Advantage Investments Inc. purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the first quarter, HoldingsChannel.com reports. The firm purchased 4,500 shares of the company’s stock, valued at approximately $493,000.

Several other institutional investors also recently made changes to their positions in ALAB. Assetmark Inc. increased its holdings in shares of Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after buying an additional 101 shares during the last quarter. Reflection Asset Management purchased a new position in shares of Astera Labs in the 4th quarter worth $25,000. Smartleaf Asset Management LLC boosted its holdings in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the last quarter. Hilltop National Bank grew its position in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the period. Finally, Aventura Private Wealth LLC purchased a new stake in Astera Labs during the fourth quarter valued at about $33,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ALAB has been the subject of several research analyst reports. Needham & Company LLC upped their price target on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Rothschild & Co Redburn initiated coverage on Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Susquehanna increased their target price on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Finally, Roth Mkm restated a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $244.75.

Insiders Place Their Bets

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $1,277,046.75. Following the completion of the sale, the director owned 60,134 shares in the company, valued at approximately $21,909,822.90. This trade represents a 5.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director owned 75,688 shares in the company, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 2,161,256 shares of company stock valued at $459,844,296. Company insiders own 10.40% of the company’s stock.

Astera Labs Trading Down 9.7%

Shares of Astera Labs stock opened at $397.02 on Wednesday. Astera Labs, Inc. has a twelve month low of $84.78 and a twelve month high of $440.99. The stock has a market cap of $68.05 billion, a price-to-earnings ratio of 268.26, a price-to-earnings-growth ratio of 5.82 and a beta of 3.95. The company has a fifty day moving average price of $275.59 and a 200 day moving average price of $191.30.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue was up 93.5% compared to the same quarter last year. During the same period last year, the company posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.